Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03150212

Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype — IBS-GO  

Constipation-predominant Irritable Bowel Syndrome Clinical Trial

Official title:
Randomized Double Blind Placebo-controlled Clinical Study : Effect of IBSIUM on the Improvement of Gastro-intestinal Disorders Associated to the Irritable Bowel Syndrome (IBS) With C Phenotype (Predominant-constipation)

Clinical Trial Summary

The main objective is to assess the effect of an 8-week daily supplementation with IbSium® (probiotic yeast Saccharomyces cerevisiae CNCM I-3856) on the improvement gastro-intestinal disorders associated to the type C IBS (constipation predominant).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03150212
Study type Interventional
Source Lesaffre International
Contact
Status Completed
Phase N/A
Start date March 20, 2017
Completion date May 9, 2019
View Details
See also
  Status Clinical Trial Phase
Terminated NCT00742872 - Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome Phase 3
Completed NCT05164861 - Safety and Efficacy of Non-alcoholic Beverage Based on Kombucha in Patients With Constipations N/A
Withdrawn NCT05321953 - The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation N/A
Not yet recruiting NCT06319729 - A Chinese Herbal Medicine for IBS-C Phase 2
Completed NCT01085643 - Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS) N/A
Recruiting NCT05757037 - Laser Acupuncture on Irritable Bowel Syndrome in Females N/A
Completed NCT05392439 - Effect of taVNS on Abdominal Pain and Other Symptoms in Constipation-predominant Irritable Bowel Syndrome N/A
Not yet recruiting NCT05921383 - Anorectal Manometry of Patients With Constipation Predominant IBS
Recruiting NCT05134584 - Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders Phase 4
Terminated NCT03336034 - Assessment of Responsiveness to Treatment by Experience Sampling Method
Not yet recruiting NCT04666155 - MOWOOT Device Treatment for Adults With Chronic Constipation N/A
Not yet recruiting NCT05941650 - To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome N/A
Completed NCT00945334 - Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome N/A
Completed NCT00912301 - Cheno Effect on Transit in Health and IBS-C Phase 2
Terminated NCT00607971 - Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C) Phase 3